CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended		184 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Cash flows from operating activities:
Net loss	$ (2,967,700)	$ (12,886,700)	$ (70,636,900)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	54,600	33,800	832,100
Amortization of discounts on convertible and promissory notes	640,000	254,800	5,315,500
Change in warrant and put and note term extension option liabilities	(3,566,900)	1,635,800	(2,349,700)
Stock-based compensation	1,137,300	1,241,300	6,732,900
Expense related to modification of warrants	204,300	508,200	1,454,200
Non-cash rent and relocation expense	56,800		56,800
Interest income on note receivable for stock purchase	(1,200)	(27,600)	(28,800)
Fair value of common stock granted for services following the Merger		340,000	852,700
Fair value of warrants granted for services and interest following the Merger	60,700	183,800	748,300
Gain on currency fluctuation	(48,600)	(53,000)	(101,600)
Fair value of additional warrants granted pursuant to exercises of modified warrants		35,900	174,000
Loss on settlements of accounts payable		78,300	78,300
Acquired in-process research and development			7,523,200
Loss on early extinguishment of debt		3,567,800	4,761,300
Fair value of Series C preferred stock, common stock, and warrants granted for services prior to the Merger			3,150,900
Fair value of common stock issued for note term modification			22,400
Consulting services by related parties settled by issuing promissory notes			44,600
Gain on sale of assets			(16,800)
Changes in operating assets and liabilities:
Unbilled contract payments receivable		106,200
Prepaid expenses and other current assets	92,700	46,200	134,400
Security deposits and other assets	(17,900)		(46,900)
Accounts payable and accrued expenses, including accrued interest	2,229,900	1,485,200	18,201,400
Deferred revenues		(13,200)
Net cash used in operating activities	(2,126,000)	(3,463,200)	(23,097,700)
Cash flows from investing activities:
Purchases of equipment, net	(9,600)	(135,400)	(825,800)
Net cash used in investing activities	(9,600)	(135,400)	(825,800)
Cash flows from financing activities:
Net proceeds from issuance of common stock and warrants, including Units	1,075,500	1,185,100	5,060,600
Proceeds from exercise of modified warrants	264,200	262,100	1,692,600
Proceeds from issuance of Platinum notes and warrants	250,000	3,222,100	7,172,100
Advance from officer	64,000		64,000
Proceeds from issuance of notes under line of credit			200,000
Proceeds from issuance of 7% note payable to founding stockholder			90,000
Net proceeds from issuance of 7% convertible notes			575,000
Net proceeds from issuance of 10% convertible notes and warrants			1,655,000
Net proceeds from issuance of preferred stock and warrants			4,198,600
Net proceeds from issuance of notes and warrants from 2006 to 2010			4,851,800
Net proceeds from issuance of February 2012 12% convertible notes and warrants			466,500
Repayment of capital lease obligations	(7,600)	(16,900)	(125,000)
Repayment of notes	(148,600)	(496,700)	(1,977,700)
Net cash provided by financing activities	1,497,500	4,155,700	23,923,500
Net (decrease) increase in cash and cash equivalents	(638,100)	557,100
Cash and cash equivalents at beginning of period	638,100	81,000
Cash and cash equivalents at end of period		638,100
Supplemental disclosure of cash flow activities:
Cash paid for interest	21,000	225,900	686,600
Cash paid for income taxes	2,700	3,700	23,200
Supplemental disclosure of noncash activities:
Forgiveness of accrued compensation and accrued interest payable to officers transferred to equity			800,000
Exercise of warrants and options in exchange for debt cancellation			112,800
Settlement of accrued and prepaid interest by issuance of Series C Preferred Stock			35,300
Conversion of 10% notes payable, net of discount, and related accrued interest of $408,600 into Series C Preferred stock			2,050,300
Issuance of Series B-1 Preferred stock for acquired in-process research and development			7,523,200
Conversion of 7% notes payable, net of discount, and related accrued interest of $3,800 into Series B Preferred stock			508,000
Conversion of accounts payable into convertible promissory notes			893,700
Conversion of accounts payable into note payable		1,558,500	4,368,800
Conversion of accounts payable into common stock		103,200	1,927,300
Conversion of accrued interest on convertible promissory notes into common stock			921,400
Notes receivable from sale of common stock to related parties upon exercise of options and warrants			149,800
Capital lease obligations			139,700
Recognition of put option and note term extension option liabilities upon issuance of Original Platinum Notes			141,200
Incremental fair value of put option and note term extension option liabilities from debt modifications			479,400
Incremental fair value of note conversion option from debt modification			1,891,200
Incremental fair value of warrant from debt modifications			276,700
Recognition of warrant liability upon adoption of new accounting standard			151,300
Fair value of warrants issued with August 2010 short term notes			130,900
Note discount upon issuance of August 2010 short term notes			320,000
Fair value of warrants issued with February 2012 12 % convertible notes			542,000
Note discount upon issuance of February 2012 12% convertible notes			495,200
Conversion of 2006/2007 and 2008/2010 Notes into Units, including accrued interest of $1,365,600			6,174,800
Conversion of all series of pre-Merger preferred stock into Units			14,534,800
Conversion of 2011 Platinum Note into Series A Preferred Stock, including accrued interest of $611,100 and conversion premium			5,763,900
Conversion of 7% note payable and accrued interest of $11,500 into common stock and warrants			19,500
Conversion of accounts payable to Morrison & Foerster, McCarthy Tetrault and Desjardins into notes payable			1,603,400
Accounts payable and cancellation premium converted into 2011 Private Placement Units			169,000
Accrued interest on Cato Holding Company note converted to note payable			90,800
Accounts payable settled in December 2011 and May/June 2012 warrant exercises		12,500	280,100
Insurance premiums settled by issuing note payable	98,300	110,100	296,900
Conversion of accrued interest and fees on February 2012 Notes into 2012 Private Placement Units		92,900	92,900
Accrued interest on July and August 2012 Notes to Platinum converted into Exchange Note		22,600	22,600
Accounts payable settled by issuance of stock or notes payable and stock		104,900	104,900
Accounts payable converted into 2012 Private Placement Units		50,000	50,000
Recognition of warrant liability upon issuance to Platinum of October 2012 Exchange Note and October 2012, February 2013 and March 2013 Investment Notes and July 2013 Convertible Note	146,800	1,690,000	1,836,800
Recognition of warrant liability for potential issuance to Platinum of Series A Exchange Warrant under the terms of the October 2012 Agreement		$ 3,068,200	$ 3,068,200